Dr. Farhatullah Syed is Head of the Advanced Cell & Gene Therapy and Genome Editing Section at KFSH&RC, Riyadh. He leads autologous, allogeneic, and CRISPR/base-edited CAR T-cell programs for hematologic malignancies and rare genetic disorders. His subspecialties include advanced cell and gene therapy, CAR T-cell development, genome editing, and clinical translation of novel therapeutics.